These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8095789)

  • 1. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
    Degos L
    Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
    [No Abstract]   [Full Text] [Related]  

  • 2. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L
    Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
    Muindi J; Frankel SR; Miller WH; Jakubowski A; Scheinberg DA; Young CW; Dmitrovsky E; Warrell RP
    Blood; 1992 Jan; 79(2):299-303. PubMed ID: 1309668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
    Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
    Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
    Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
    J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L
    Curr Opin Oncol; 1992 Feb; 4(1):45-52. PubMed ID: 1317215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F; Biondi A; Pelicci PG
    Blood; 1995 Oct; 86(8):3264-5. PubMed ID: 7579425
    [No Abstract]   [Full Text] [Related]  

  • 11. [Induction of differentiation of human leukemia cells].
    Kizaki M; Nakajima H; Ikeda Y
    Hum Cell; 1992 Jun; 5(2):103-9. PubMed ID: 1382572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation therapy of leukemia.
    Degos L
    Leuk Lymphoma; 1994; 13 Suppl 1():39-43. PubMed ID: 8075578
    [No Abstract]   [Full Text] [Related]  

  • 13. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
    Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
    Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation therapy of acute promyelocytic leukemia.
    Chen Z
    Chin Med J (Engl); 1996 Mar; 109(3):179-82. PubMed ID: 8758302
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
    Frankel SR; Miller WH; Dmitrovsky E
    Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proposals for the objective indices for evaluating the differentiation of leukemic cells by all-trans retinoic acid in the patients with acute promyelocytic leukemia].
    Nakajima H; Kizaki M; Takayama N; Kawai Y; Watanabe K; Okamoto S; Ikeda Y
    Rinsho Ketsueki; 1996 Mar; 37(3):208-13. PubMed ID: 8727344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinoic acid receptor alpha gene rearrangement as specific marker of acute promyelocytic leukemia and its use in the study of cell differentiation].
    Zhu Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):229-33, 255. PubMed ID: 1327453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 20. The maturation of differentiation therapy.
    Cheson BD
    N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.